MAGENTA THERAPEUTICS INC (MGTA)
US55910K1088 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -68.69M | -76.46M | -71.14M | -74.94M | -76.77M | |||
| Depreciation Amortization | 1.36M | 1.93M | 2.02M | 1.98M | 1.84M | |||
| Change In Working Capital | -19.51M | -2.70M | -1.53M | -1.19M | 8.83M | |||
| Other non cash items | 14.21M | 10.15M | 11.11M | 10.12M | 8.99M | |||
| OPERATING CASH FLOW | -72.64M | -67.09M | -59.53M | -64.02M | -57.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -403.00K | -314.00K | -1.26M | -400.00K | -3.06M | |||
| Other Investing Activity | 76.23M | -9.50M | 44.69M | -10.23M | 4.59M | |||
| INVESTING CASH FLOW | 75.83M | -9.81M | 43.43M | -10.63M | 1.53M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 3.02M | 3.50M | 68.04M | 62.90M | |||
| Other Financing Activity | N/A | -141.00K | 86.10M | -297.00K | -600.00K | |||
| FINANCING CASH FLOW | 2.83M | 2.88M | 89.60M | 67.74M | 62.30M | |||
| CHANGE IN CASH | 6.02M | -74.02M | 73.50M | -6.92M | 6.73M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -72.64M | -67.09M | -59.53M | -64.02M | -57.10M | |||
| Capital Expenditure | -403.00K | -314.00K | -1.26M | -400.00K | -3.06M | |||
| FREE CASH FLOW | -73.04M | -67.40M | -60.80M | -64.42M | -60.16M | |||
All data in USD